United States (US) Parkinsons Disorder Drugs Market (2025-2031) | Competitive Landscape, Growth, Segmentation, Size & Revenue, Forecast, Value, Share, Analysis, Companies, Industry, Trends, Outlook

Market Forecast By Drug Class (Decarboxylase Inhibitors, Dopamine Agonists, Monoamine Oxidase Type B (MAO-B) Inhibitor, Others), By Route of Administration (Oral, Injection, Transdermal), By Distribution Channel (Hospitals, Online Pharmacy, Others) And Competitive Landscape
Product Code: ETC9972886 Publication Date: Sep 2024 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Summon Dutta No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United States (US) Parkinsons Disorder Drugs Market Outlook
  • Market Size of United States (US) Parkinsons Disorder Drugs Market, 2024
  • Forecast of United States (US) Parkinsons Disorder Drugs Market, 2031
  • Historical Data and Forecast of United States (US) Parkinsons Disorder Drugs Revenues & Volume for the Period 2021- 2031
  • United States (US) Parkinsons Disorder Drugs Market Trend Evolution
  • United States (US) Parkinsons Disorder Drugs Market Drivers and Challenges
  • United States (US) Parkinsons Disorder Drugs Price Trends
  • United States (US) Parkinsons Disorder Drugs Porter's Five Forces
  • United States (US) Parkinsons Disorder Drugs Industry Life Cycle
  • Historical Data and Forecast of United States (US) Parkinsons Disorder Drugs Market Revenues & Volume By Drug Class for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Parkinsons Disorder Drugs Market Revenues & Volume By Decarboxylase Inhibitors for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Parkinsons Disorder Drugs Market Revenues & Volume By Dopamine Agonists for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Parkinsons Disorder Drugs Market Revenues & Volume By Monoamine Oxidase Type B (MAO-B) Inhibitor for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Parkinsons Disorder Drugs Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Parkinsons Disorder Drugs Market Revenues & Volume By Route of Administration for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Parkinsons Disorder Drugs Market Revenues & Volume By Oral for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Parkinsons Disorder Drugs Market Revenues & Volume By Injection for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Parkinsons Disorder Drugs Market Revenues & Volume By Transdermal for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Parkinsons Disorder Drugs Market Revenues & Volume By Distribution Channel for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Parkinsons Disorder Drugs Market Revenues & Volume By Hospitals for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Parkinsons Disorder Drugs Market Revenues & Volume By Online Pharmacy for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Parkinsons Disorder Drugs Market Revenues & Volume By Others for the Period 2021- 2031
  • United States (US) Parkinsons Disorder Drugs Import Export Trade Statistics
  • Market Opportunity Assessment By Drug Class
  • Market Opportunity Assessment By Route of Administration
  • Market Opportunity Assessment By Distribution Channel
  • United States (US) Parkinsons Disorder Drugs Top Companies Market Share
  • United States (US) Parkinsons Disorder Drugs Competitive Benchmarking By Technical and Operational Parameters
  • United States (US) Parkinsons Disorder Drugs Company Profiles
  • United States (US) Parkinsons Disorder Drugs Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the United States (US) Parkinsons Disorder Drugs Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United States (US) Parkinsons Disorder Drugs Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Parkinsons Disorder Drugs Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Parkinsons Disorder Drugs Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Parkinsons Disorder Drugs Market - Industry Life Cycle

3.4 United States (US) Parkinsons Disorder Drugs Market - Porter's Five Forces

3.5 United States (US) Parkinsons Disorder Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 United States (US) Parkinsons Disorder Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.7 United States (US) Parkinsons Disorder Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4 United States (US) Parkinsons Disorder Drugs Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of Parkinson's disease in the United States

4.2.2 Growing geriatric population in the country

4.2.3 Technological advancements in drug development for Parkinson's disorder

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for drug approval

4.3.2 High cost of Parkinson's disorder drugs

4.3.3 Limited awareness about available treatment options among patients

5 United States (US) Parkinsons Disorder Drugs Market Trends

6 United States (US) Parkinsons Disorder Drugs Market, By Types

6.1 United States (US) Parkinsons Disorder Drugs Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 United States (US) Parkinsons Disorder Drugs Market Revenues & Volume, By Drug Class, 2021- 2031F

6.1.3 United States (US) Parkinsons Disorder Drugs Market Revenues & Volume, By Decarboxylase Inhibitors, 2021- 2031F

6.1.4 United States (US) Parkinsons Disorder Drugs Market Revenues & Volume, By Dopamine Agonists, 2021- 2031F

6.1.5 United States (US) Parkinsons Disorder Drugs Market Revenues & Volume, By Monoamine Oxidase Type B (MAO-B) Inhibitor, 2021- 2031F

6.1.6 United States (US) Parkinsons Disorder Drugs Market Revenues & Volume, By Others, 2021- 2031F

6.2 United States (US) Parkinsons Disorder Drugs Market, By Route of Administration

6.2.1 Overview and Analysis

6.2.2 United States (US) Parkinsons Disorder Drugs Market Revenues & Volume, By Oral, 2021- 2031F

6.2.3 United States (US) Parkinsons Disorder Drugs Market Revenues & Volume, By Injection, 2021- 2031F

6.2.4 United States (US) Parkinsons Disorder Drugs Market Revenues & Volume, By Transdermal, 2021- 2031F

6.3 United States (US) Parkinsons Disorder Drugs Market, By Distribution Channel

6.3.1 Overview and Analysis

6.3.2 United States (US) Parkinsons Disorder Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F

6.3.3 United States (US) Parkinsons Disorder Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F

6.3.4 United States (US) Parkinsons Disorder Drugs Market Revenues & Volume, By Others, 2021- 2031F

7 United States (US) Parkinsons Disorder Drugs Market Import-Export Trade Statistics

7.1 United States (US) Parkinsons Disorder Drugs Market Export to Major Countries

7.2 United States (US) Parkinsons Disorder Drugs Market Imports from Major Countries

8 United States (US) Parkinsons Disorder Drugs Market Key Performance Indicators

8.1 Number of clinical trials for new Parkinson's disorder drugs in the United States

8.2 Adoption rate of innovative treatment approaches for Parkinson's disease

8.3 Patient satisfaction and adherence rates with prescribed medications

8.4 Number of patents filed for new drug formulations or delivery methods

8.5 Investment in research and development for Parkinson's disorder drugs in the United States

9 United States (US) Parkinsons Disorder Drugs Market - Opportunity Assessment

9.1 United States (US) Parkinsons Disorder Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 United States (US) Parkinsons Disorder Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.3 United States (US) Parkinsons Disorder Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10 United States (US) Parkinsons Disorder Drugs Market - Competitive Landscape

10.1 United States (US) Parkinsons Disorder Drugs Market Revenue Share, By Companies, 2024

10.2 United States (US) Parkinsons Disorder Drugs Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Related Reports

Industry Events and Analyst Meet

Whitepaper

Read All